Olink Holding AB (publ) is a Sweden-based company engaged in the marketing and sales of biotechnological products and services. The Company offers a technique to identify actionable biomarkers, with a focus on the human plasma proteome. The Company operates in Sweden and the USA.

Employees

707

Sector

Office Equipment

Calendar

2024-11-06 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement and Estimates

More financial data

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-09 pm EDT			5-day change	1st Jan Change
26.08 ^USD	+0.31%		-.--%	+3.70%

Jul. 25	Thermo Fisher opens the biotech ball with a bang
Jul. 11	Olink Holding AB(NasdaqGM:OLK) dropped from S&P Global BMI Index	CI

Capitalization	3.13B	P/E ratio 2022	-235x	P/E ratio 2023	-98.7x
Enterprise value	3.03B	EV / Sales 2022	21.1x	EV / Sales 2023	17.9x
Free-Float	33.59%	Yield 2022 *	-	Yield 2023	-

Thermo Fisher opens the biotech ball with a bang	Jul. 25
Olink Holding AB(NasdaqGM:OLK) dropped from S&P Global BMI Index	Jul. 10	CI
Thermo Fisher Scientific Completes Acquisition of Olink	Jul. 10	MT
Olink Holding AB(NasdaqGM:OLK) dropped from NASDAQ Composite Index	Jul. 09	CI
Thermo Fisher Scientific Inc. completed the acquisition of Olink Holding AB from Summa Equity AB and others.	Jul. 09	CI
Olink Holding Receives UK Approval for Thermo Fisher's $26 per Share Tender Offer	Jul. 08	MT
Olink® Target 48 Immune Surveillance Panel ? the Next Frontier in Immune Biomarker Profiling with Absolute Confidence	Jun. 06	CI
Researchers Use Olink®? Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis	May. 30	CI
Olink Holding's Q1 Net Loss Widens, Revenue Rises	May. 13	MT
Olink Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 13	CI
UK Competition Regulator Opens Probe on Thermo Fisher, Olink Merger	May. 10	MT
UK Competition Watchdog Opens Probe on Thermo Fisher Scientific's Acquisition of Olink	May. 10	MT
UK's CMA kicks off probe into Thermo Fisher-Olink deal	May. 10	RE

Morgan Stanley Adjusts Price Target on Olink Holding to $26 From $18, Maintains Equal-Weight Rating	23-10-24	MT
Scotiabank Downgrades Olink Holding to Sector Perform From Sector Outperform, Cuts Price Target to $26 From $29	23-10-18	MT
Morgan Stanley Adjusts Price Target on Olink to $18 From $19, Maintains Equalweight Rating	23-08-10	MT
Goldman Sachs Adjusts Price Target on Olink Holding to $18 From $16, Maintains Neutral Rating	23-02-22	MT
Scotiabank Initiates Olink Holding AB at Sector Outperform With $27 Price Target	23-01-05	MT

OLIK HLDG Stock

Equities

OLK

US6807101000

Office Equipment

Valuation: OLIK HLDG

Chart: OLIK HLDG

Latest news: OLIK HLDG

Last Transcript: OLIK HLDG

Analysts' recommendations: OLIK HLDG

Press Releases: OLIK HLDG

News in other languages: OLIK HLDG

Quotes and Performance

Course Extremes

Managers and Directors: OLIK HLDG

ETFs: OLIK HLDG

Scientific & Precision Equipment

Financials

Company Profile

Income Statement and Estimates

Notice to attend the Extra General Meeting of Olink Holding AB (publ)	Jul. 11	GL
Olink Announces Receipt of CMA Clearance for Proposed Acquisition by Thermo Fisher	Jul. 08	GL
Report from the Extra General Meeting of Olink Holding AB (publ) on 5 July 2024	Jul. 05	GL
Olink® Introduces Global Network of Certified Service Providers to Accelerate Protein Biomarker Discovery	Jul. 03	GL
Notice to attend the Extra General Meeting of Olink Holding AB (publ)	Jun. 11	GL

Thermo Fisher Scientific: opent het bal in de biotech met veel grandeur	Jul. 27
Thermo Fisher apre le danze del biotech con il botto	Jul. 27
Thermo Fisher: Besser geht's kaum	Jul. 26
Thermo Fisher ouvre le bal dans la biotech en grande pompe	Jul. 25
Amazon com : Meta, Amazon, Apple...les valeurs à suivre aujourd'hui à Wall Street -	Feb. 02

Director	Title	Age	Since
Jon Aron Olof Heimer CEO	Chief Executive Officer	57	20-11-30
Carl Raimond PSD	President	53	20-07-31
Oskar Hjelm DFI	Director of Finance/CFO	39	20-02-29

Name	Weight	AuM	1st Jan change	Investor Rating
BLACKROCK FUTURE INNOVATORS ETF - USD	0.15%	5 M€	-1.80%	-
LEVERAGE SHARES -3X SHORT BIOTECHNOLOGY ETP SECURITIES - USD	0.12%	0 M€	0.00%	-
FIRST TRUST IPOX EUROPE EQUITY OPPORTUNITIES ETF - DISTRIBUTING - USD	0.10%	4 M€	+13.23%
LEVERAGE SHARES 3X LONG BIOTECHNOLOGY ETP SECURITIES - USD	0.06%	0 M€	0.00%	-

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
OLIK HLDG	+0.31%	-.--%	+71.24%	-12.34%	3.25B
SHIMADZU CORPORATION	-0.21%	-3.88%	+13.01%	-14.13%	9.56B
TECAN GROUP AG	+1.58%	+0.35%	-15.86%	-51.72%	4.25B
JEOL LTD.	-0.13%	-13.63%	+20.06%	-38.06%	2.04B
ECKERT & ZIEGLER SE	+1.82%	-4.13%	+33.57%	-69.13%	939M
PARK SYSTEMS CORP.	+2.68%	-5.42%	-1.23%	+38.66%	893M
NINGBO YONGXIN OPTICS CO.,LTD	-1.87%	+9.38%	-36.90%	-13.85%	872M
FOCUSED PHOTONICS (HANGZHOU), INC.	+0.90%	+0.72%	-34.50%	-48.18%	705M
PHENIX OPTICAL COMPANY LIMITED	-1.14%	+1.47%	-12.86%	+9.61%	665M
SVG TECH GROUP CO.,LTD.	+7.15%	-3.09%	-38.29%	-51.78%	575M
Average	+1.04%	-2.87%	-0.17%	-25.09%	2.38B
Weighted average by Cap.	+0.40%	-3.72%	+11.49%	-24.10%

	2022	2023
Net sales	140M	170M
Net income	-12.85M	-31.6M
Net Debt	-65.67M	-94.17M

1 day	+0.31%
3 months	+5.80%
6 months	+10.27%
Current year	+3.70%